Navigation Links
Leeds researchers test benefit of fish oil in bowel cancer spread
Date:7/1/2011

Researchers from the University of Leeds will carry out a series of experiments to see whether fish oil can prevent or treat the spread of bowel cancer to the liver.

The cancer scientists will test the effectiveness of pure Eicosapentaenoic Acid (EPA) - a naturally occurring omega-3 fish oil component which is widely available in mixed fish oil preparations in health stores and supermarkets nationwide.

Gastroenterologist Professor Mark Hull, based at the Leeds Institute of Molecular Medicine, University of Leeds, will use results from the initial experiments to design a future clinical trial to test the effect of pure EPA in humans at risk of or with metastatic bowel cancer.

The research is being funded by Yorkshire Cancer Research and it will hopefully back up existing evidence from a previous clinical trial from Leeds that showed that EPA may prevent large bowel polyps, the benign precursors of large bowel cancer.

"We and others have already demonstrated that EPA might have beneficial effects at a later stage after development of malignancy," said Professor Hull.

"These new tests will help us establish whether EPA can prevent the spread of large bowel cancer to the liver, the commonest site of spread and eventual cancer-related death which we call metastasis.

"The tests will also help us establish how EPA reduces growth of established liver metastases in an experimental system prior to design of the clinical trial."

The trial published last year, which involved 55 patients with the rare inherited condition Familial Adenomatous Polyposis (FAP) thought to be responsible for about one in every 100 bowel cancers, saw a significant reduction in the size and number of pre-cancerous growths, known as polyps, in those patients who took a two gram daily dose of EPA in the free fatty acid form over a six month period.

Another promising study currently being led by the Leeds team involving nearly a 1000 patients, is investigating whether taking EPA alone, or together with aspirin, can help stop pre-cancerous growths from developing in the bowel.


'/>"/>

Contact: Paula Gould
p.a.gould@leeds.ac.uk
44-133-343-8059
University of Leeds
Source:Eurekalert

Related medicine news :

1. Leeds Teaching Hospitals Trust and RSLSteeper Team Up to Help Paralympian Walk His Sister Down the Aisle
2. Fox Chase researchers identify new mechanism used by cells to reverse silenced genes
3. BUSM researchers find herbal medicine treatment reduces inflammation in allergen-induced asthma
4. Researchers at Oregon Health & Science University discover MS-like disease in monkeys
5. Drug shows improved kidney function for type 2 diabetics, UT Southwestern researchers report
6. Researchers identify components of speech recognition pathway in humans
7. Wayne State University researchers win grant from the NSF to target tinnitus
8. Researchers find CDT biomarker ineffective for identifying unhealthy alcohol use
9. Mayo Clinic researchers use human vaccine to cure prostate cancer in mice
10. UT Southwestern researchers uncover why ketamine produces a fast antidepressant response
11. Researchers report progress using iPS cells to reverse blindness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica ... in thought leadership , media relations, social media, content marketing and SEO, ... be powered through Act-On, an intuitive marketing automation platform. , Rosica will now ...
(Date:2/23/2017)... ... 23, 2017 , ... On February 22, 2017 the U.S. ... to withdraw previous guidance issued by the Obama Administration requiring schools to treat ... 2016 by the Obama Administration came in response to a growing number of ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The American Cleft ... ACPA’s 74th Annual Meeting. KLS is a longtime supporter of the event. , ... exhibitor and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... Institute for Health and Care Excellence (NICE) framework. The agreement allows purchasers ... (NHS) to search, order and purchase medical and healthcare-related content through GOBI ...
(Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... DUBLIN , Feb 24, 2017 Research ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... provides drug pricing data and benchmarks in the global Urinary Incontinence ... What are the key drugs marketed for Urinary Incontinence ...
(Date:2/23/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device company ... the urology market, will release financial results for the ... before the market open on Thursday, March 9, 2017. ... call and webcast to discuss its financial results the ... a.m. Eastern Time (10:00 a.m. Central Time). Darin ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Oesophageal Cancer ... and benchmarks in the global Oesophageal Cancer market. The ... are the key drugs marketed for Oesophageal Cancer and their clinical ...
Breaking Medicine Technology: